10.1146/annurev-nutr-071816-064916 Annu
doi: 10.1371/journal.pone.0047891 132 ArizaMERivaillerPGlaserRChenMWilliamsMV
Side-effect profile observed in research Nausea, diarrhoea, constipation, and vomiting were the most frequently reported events in the Phase 2 trial, generally mild-to-moderate and most common during the dose-escalation phase
Here are some other conditions that have been associated with Mounjaro: Gallbladder disease (cholelithiasis/cholecystitis): reported with GLP-1/GIP therapyseek care for persistent RUQ pain/fever/jaundice Acute kidney injury: often secondary to dehydration from GI effectsmonitor renal function if symptoms are significant Hypoglycemia: risk increases when used with insulin or secretagogues
Dimethyl sulfoxide combined with intravesical cocktail therapy can lead to better outcomes after treatment, more effective reduction of inflammation, and higher quality of life for patients with interstitial cystitis.7 Other therapies for interstitial cystitis include injecting or infusing hyaluronic acid, botulinum toxin A, triamcinolone, resiniferatoxin, and platelet-rich plasma